Chronic Kidney Disease Market to Grow at a CAGR of 6.3% from 2025 to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Chronic Kidney Disease Market?

The chronic kidney disease market has shown significant expansion in recent years. Its value is expected to increase from $70.65 billion in 2024 to $74.87 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.0%. This past growth can be attributed to the hypertension and diabetes epidemic, an aging population, unhealthy lifestyles, healthcare access disparities, and medical advances.

The chronic kidney disease market is poised for significant expansion in the upcoming years. It is forecast to achieve a size of $95.43 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 6.3%. This expected increase during the forecast period stems from factors such as a strong emphasis on healthcare policies, progress in precision medicine, an uptick in obesity rates, the spread of chronic diseases, and better access to healthcare. Notable trends influencing this period include early screening campaigns, the adoption of telemedicine and remote monitoring, patient empowerment initiatives, local community-based care programs, and the integration of nutritional therapy.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11969&type=smp

Which Major Market Drivers Are Shaping The Future Of The Chronic Kidney Disease Market?

The growing occurrence of kidney disease is projected to stimulate the chronic kidney disease market’s future expansion. Kidney diseases are defined as a range of conditions that impair the kidneys’ function and structure. Treatments for kidney disease aim to regulate patient blood pressure and lessen protein loss to prevent further kidney damage, alleviate symptoms, and avert complications. For example, in July 2022, the Centers for Disease Control and Prevention, a US-based national public health agency, reported that about 15%, or 37 million people in the US, were living with kidney disease. As a result, the increasing prevalence of kidney disease is propelling the growth of the chronic kidney disease market.

How Is The Chronic Kidney Disease Market Classified Into Different Segments?

The chronic kidney diseasemarket covered in this report is segmented –

1) By Diagnosis: Blood Test; Urine Test; Imaging Test; Kidney Biopsy

2) By Treatment: Drugs; Dialysis; Kidney Transplant; ACE Inhibitors; Blood Test; Other Treatments

3) By Route of Administration: Oral; Intravenous; Subcutaneous

4) By End-User: Hospital And Clinics; Ambulatory Surgery Centers (ASCs); Dialysis Centers; Other End-Users

Subsegments:

1) By Blood Test: Serum Creatinine Test; Glomerular Filtration Rate (GFR) Test; Blood Urea Nitrogen (BUN) Test; Electrolyte Tests

2) By Urine Test: Urinalysis; 24-hour Urine Collection; Urine Protein Test; Urine Albumin-To-Creatinine Ratio (ACR)

3) By Imaging Test: Ultrasound; CT Scan; MRI; X-ray

4) By Kidney Biopsy: Percutaneous Kidney Biopsy; Open Kidney Biopsy; Laparoscopic Kidney Biopsy

What Are The Major Trends Driving The Growth Of The Chronic Kidney Disease Market?

Product innovation represents a significant and increasingly popular trend within the chronic kidney disease market. Companies operating in the chronic kidney disease market are focused on developing innovative products to maintain their standing. For example, in August 2022, Bayer, a Germany-based biotechnology and pharmaceutical company, released the innovative medicine Kerendia (finerenone) with the aim of slowing the progression of chronic kidney disease in diabetes patients. This medication is a pioneering non-steroidal, selective mineralocorticoid receptor antagonist, differing from currently available treatments. It works by inhibiting the overactivation of mineralocorticoid receptors (MR), which contributes to the advancement of CKD and cardiovascular damage.

Which Leading Players Are Enhancing Their Chronic Kidney Disease Market Presence Worldwide?

Major companies operating in the chronic kidney disease market include Pfizer Inc, Johnson and Johnson Services Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott laboratories Inc., GlaxoSmithKline PLC, Takeda Pharmaceuticals Ltd., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Novo Nordisk AS, Siemens Healthineers AG, AstraZeneca Pharmaceuticals LP, Teva Pharmaceutical Industries Ltd., Beckman Coulter Inc., Kissei Pharmaceutical Co. Ltd., Akebia Therapeutics Inc., Mission Therapeutics Ltd., Tricida Inc., Regulus Therapeutics Inc., Goldfinch Bio Co, Alio Inc., Monogram Health, Strive Health, Maze Therapeutics, ProKidney Corp

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/chronic-kidney-disease-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Chronic Kidney Disease Market?

North America was the largest region in the chronic kidney disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic kidney disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Chronic Kidney Disease Market Report:

https://www.thebusinessresearchcompany.com/customise?id=11969&type=smp

Browse Through More Reports Similar to the Global Chronic Kidney Disease Market 2025, By The Business Research Company

Polymerase Chain Reactions Devices Reagents And Uses Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/polymerase-chain-reactions-devices-reagents-and-uses-global-market-report

Waterbased Adhesives Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/waterbased-adhesives-global-market-report

Ethylene Propylene Epdm Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ethylene-propylene-epdm-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795